U.S. Healthcare Services Stock News

Dyne Therapeutics (DYN) is back in focus after reporting fourth quarter and full year 2025 results that highlight ongoing net losses alongside continued investment in its neuromuscular disease pipeline and upcoming regulatory milestones. See our latest analysis for Dyne Therapeutics. Dyne’s recent earnings update, clinical milestones and fresh shelf registration have come against a weak run in the share price, with a 30 day share price return of an 18.39% decline and a 90 day share price...

If you are wondering whether Manhattan Associates is trading at a fair price or not, it helps to step back and look at what the current share price is really implying about the business. The stock closed at US$148.26, with a 7 day return of 11.2%, a 30 day return of a 1.8% decline, a year to date return of an 11.4% decline, and a 1 year return of a 13.5% decline, which may have caught the attention of investors thinking about risk and reward. These moves sit against a backdrop where longer...

If you are wondering whether EPAM Systems is starting to look interesting at its current share price, you are not alone. This article focuses squarely on what that price might imply about value. The stock recently closed at US$140.77, with returns of 9.3% over 7 days but declines of 32.5% over 30 days and 29.8% year to date. Recent trading has been volatile for investors looking at the 1 year return of 28.9% and multi year returns of 53.9% over 3 years and 59.9% over 5 years. These moves sit...

NNN REIT, Inc. recently announced that long-time board member and Chairperson Steven D. Cosler retired from the Board on February 18, 2026, and was succeeded as Chair by independent director Edward J. Fritsch, a former President and CEO of Highwoods Properties and past Nareit national chair. Fritsch’s deep REIT and industry governance background could influence how NNN REIT’s Board oversees capital allocation, portfolio decisions, and long-term corporate priorities. We’ll now examine how...

Nomad Foods (NOMD) is back in focus after its Q4 2025 earnings release, where the company reported a quarterly net loss and issued cautious 2026 guidance that points to further organic sales pressure. See our latest analysis for Nomad Foods. That weak Q4 and cautious 2026 outlook have hit sentiment hard, with a 7 day share price return of 18.98% and a 1 year total shareholder return of 45.77%. This suggests momentum has been fading despite ongoing buybacks and recent earnings commentary. If...

Uniti Group reported fourth-quarter 2025 revenue of US$917.3 million with a net loss of US$305.7 million, while full-year 2025 revenue rose to US$2.23 billion alongside net income of US$1.30 billion, and the company guided to US$3.61–US$3.66 billion in 2026 revenue with a net loss of US$410–US$360 million. At the same time, Uniti Wholesale accelerated its 2026 fiber expansion with new data center on-ramps and the FastWaves program, aiming to cut 100G and 400G wavelength delivery times to...

BKV (BKV) is back in the spotlight after reporting fourth quarter and full year 2025 results that moved from a net loss to net income, along with higher reported revenue and production volumes. See our latest analysis for BKV. The earnings release and production guidance have landed alongside a strong run in the stock, with a recent 1-day share price return of 0.22% and year to date share price return of 14.21%. Over the past year, BKV’s total shareholder return of 63.48% and 90 day share...

Intuitive Machines (LUNR) is back in focus after announcing that subsidiary Lanteris Space Systems was chosen by L3Harris Technologies to supply 18 spacecraft platforms for the Space Development Agency’s Tranche 3 Tracking Layer missile tracking program. See our latest analysis for Intuitive Machines. The contract news arrives after a mixed run in the share price, with a 78.43% 90 day share price return easing back in the past month even as the 1 year total shareholder return sits at 35.12%...

In February 2026, Array Technologies reported fourth-quarter 2025 results showing quarterly sales falling to US$226.04 million, a wider quarterly net loss of US$145.75 million, and a goodwill impairment charge of US$102.56 million, while full-year sales rose to US$1.28 billion and full-year net losses narrowed to US$52.24 million. At the same time, the company issued 2026 revenue guidance of US$1.4 billion to US$1.5 billion and upsized its revolving credit facility to US$370 million,...

Data breach puts Madison Square Garden Entertainment (MSGE) under closer investor scrutiny Madison Square Garden Entertainment (MSGE) recently reported a data breach tied to an Oracle eBusiness Suite vulnerability, exposing sensitive personal information and drawing legal scrutiny from Edelson Lechtzin LLP. See our latest analysis for Madison Square Garden Entertainment. The data breach headlines arrive after a period of mixed trading, with the latest share price at US$60.78 and shorter term...

Comfort Systems USA (NYSE:FIX) reported a transformative FY2025 performance, featuring substantial revenue growth, wider margins, and a much larger backlog. The FY2025 results indicate a structural shift in the business, with the backlog providing multi year visibility on future work. These developments suggest a materially different earnings base for the company compared with recent years. For shareholders, the fresh FY2025 numbers come on top of an already very strong share price run...

Root (ROOT) is back in focus after reporting fourth quarter and full year 2025 results, with revenue and earnings per share figures giving investors fresh detail on the insurer’s recent operating performance. See our latest analysis for Root. Root’s recent earnings have arrived following a sharp pullback in its share price, with a 30 day share price return of 23.06% and a year to date share price return showing a 32.58% decline. The 1 year total shareholder return of a 63.88% decline...

Vestis (VSTS) just reported a softer Q4, with revenue down 3.2% year on year to US$663.4 million and earnings per share matching expectations. The stock has climbed 7.5% since the release. See our latest analysis for Vestis. That post earnings bounce sits on top of a mixed track record, with a 30 day share price return of 16.7% and a 90 day gain of 19.8%, but a 1 year total shareholder return of 31% in the red. For longer term holders, this suggests that momentum is still rebuilding rather...

Hinge Health (NYSE:HNGE) has filed a significant shelf registration for Class A Common Stock linked to an ESOP related transaction. The filing provides flexibility to offer shares over time, affecting the company’s capital structure and potential funding options. This move highlights fresh corporate activity that goes beyond day to day operations and routine disclosures. Hinge Health focuses on digital musculoskeletal care, connecting patients with virtual physical therapy and related...

Global Payments (GPN) is back in focus after its latest earnings, where muted core revenue growth and cautious analyst commentary contrasted with fresh board appointments, a new dividend, a large buyback, and renewed partnerships. See our latest analysis for Global Payments. Those mixed signals are showing up in the price too, with the 1 month share price return of 8.31% and a year to date gain of 2.87% sitting against a 1 year total shareholder return decline of 21.01%. This suggests recent...

DXP Enterprises is shifting its core focus from oil and gas distribution to a broader industrial platform. The company is targeting sectors such as Water, Wastewater, Fire, and Data Centers, supported by fresh liquidity. An acquisition driven expansion plan is central to this repositioning of NasdaqGS:DXPE. DXP Enterprises, trading on NasdaqGS:DXPE, is drawing attention as it reshapes its business around essential infrastructure and industrial markets. The stock closed at $140.47, with a...

In the past quarter, WEX reported revenues up 5.7% year on year, beating analyst expectations by 1.2% even as its full-year revenue guidance came in slightly below forecasts. The company emphasized that recent actions to accelerate growth and improve performance led it to raise full-year guidance more than any peer in the diversified financial services segment. Next, we'll examine how WEX's revenue beat and relatively strong guidance raise could influence its existing investment narrative...

Calumet (NasdaqGS:CLMT) reports significant debt reduction and major cost cuts as part of a wider operational reset. The company secures a large loan from the U.S. Department of Energy to support its Montana Renewables MaxSAF 150 expansion. Management highlights record Specialty Products production and ongoing portfolio changes as it advances its renewable fuels strategy. Calumet comes into this news cycle with its shares at $27.89 and a very large 5 year return, indicating the stock has...

In February 2026, Samsara Inc. launched its latest-generation Asset Tag and ultra-compact Asset Tag XS, pairing rugged, long-life hardware with an AI-powered theft and loss workflow backed by a dense industrial Bluetooth mesh and Hubble’s terrestrial smartphone network. The integration of millions of Samsara-connected devices with 90 million consumer smartphones gives the company an unusually broad, hybrid industrial–consumer network aimed at improving real-time visibility and recovery of...

In late February 2026, Arlo Technologies reported past fourth-quarter 2025 results showing revenue of US$141.3 million and net income of US$5.76 million, alongside full-year 2025 revenue of US$529.3 million and net income of US$14.93 million, and issued first-quarter 2026 guidance for revenue of US$135–145 million and diluted EPS of US$0.01–0.07. These results highlighted a shift from losses to earnings and underscored how growing, higher-margin subscription and services revenue is reshaping...

If you are wondering whether Chubb's current share price reflects its true worth, starting with a clear look at valuation can help you decide how it might fit into your portfolio. Chubb shares last closed at US$338.30, with returns of 0.4% over 7 days, 9.3% over 30 days, 9.1% year to date, 20.6% over 1 year, 70.8% over 3 years and 115.4% over 5 years. This provides plenty of recent price history to weigh against fundamentals. Recent news around the insurance sector, capital strength and...

Why Catalyst Pharmaceuticals (CPRX) Is On Investors’ Radar Now Catalyst Pharmaceuticals (CPRX) is in focus after reporting record Q4 and full year 2025 results, driven by product revenues from FIRDAPSE and AGAMREE, and issuing 2026 revenue guidance of US$615 million to US$645 million. See our latest analysis for Catalyst Pharmaceuticals. Despite record results and new 2026 guidance, Catalyst Pharmaceuticals’ recent share price performance has been fairly muted, with a 3.6% 90 day share price...

A securities fraud class action lawsuit has been filed against CoreWeave (NasdaqGS:CRWV). The complaint alleges misleading statements about the company’s ability to meet customer demand. It also highlights risks tied to reliance on a single third party data center supplier. The case raises questions about risk disclosure, corporate governance and potential financial liabilities. CoreWeave, currently trading at $73.78, is under sharper scrutiny as this lawsuit lands at a time when the stock...

In the wake of the January 2025 wildfires, Mercury General reported stronger fourth quarter and full-year 2025 results, including higher revenue, net income, and an improved combined ratio as underwriting performance rebounded. The company’s ability to restore underwriting discipline through rate increases and portfolio remediation has renewed confidence in its earnings visibility and operational resilience. We’ll now examine how this underwriting rebound and clearer earnings outlook may...